Search Results

Keywords: "United Kingdom"

Growing Momentum: Seven Global Players Worth Watching

September 2, 2019 · Updated June 6, 2021

There seven businesses are worth watching at they attempt to capitalize on the numerous business opportunities in the global marijuana market for entrepreneurs and companies with ambition. And check mjbizdaily.com/intl often for new updates. Looking for where else the action is taking place in the global cannabis market? Here is our list of seven countries to keep […]

Read More

First commercial export of nonpsychoactive cannabis from Colombia reaches UK

August 1, 2019 · Updated December 1, 2020

Bogota-based Clever Leaves announced that the first Colombian shipment of nonpsychoactive cannabis products for commercial sale reached London’s Heathrow Airport on July 27, and the health-related goods cleared customs Wednesday. The products, which were exported as a food supplement, will soon be available for sale in the United Kingdom and other European Union countries, according to […]

Read More

Craft Cannabis: Infusing Methods

August 1, 2019 · Updated June 6, 2021

As marijuana cultivators work to define “craft cannabis,” makers of infused products are trying to do the same—and explain to consumers why (in some cases) they should be willing to pay more for such items. What defines cannabis-infused craft products depends on whom you ask. For some, it means using sun-grown cannabis for extracted oils […]

Read More

Dixie Brands’ board loses two Auxly marijuana executives

July 29, 2019 · Updated July 30, 2019

Two top executives at the Canadian-based Auxly Cannabis Group resigned from the board of Dixie Brands, a Denver-based maker of cannabis-infused products. Hugo Alves, the president of Auxly, and Michael Lickver, senior vice president of strategy for the Vancouver, British Columbia-based cannabis company, announced their resignations Monday. No reason for their departures was given in a Dixie […]

Read More

British tobacco giant invests CA$123 million in Canadian cannabis firm Auxly

July 26, 2019 · Updated July 30, 2019

Imperial Brands said it will invest 123 million Canadian dollars ($93.4 million) in a British Columbia cannabis company, the United Kingdom tobacco giant’s latest foray into the marijuana industry. With the investment, Imperial is taking a 19.9% stake in Auxly Cannabis Group, an international cannabis company based in Vancouver, British Columbia. The two companies also […]

Read More

GW Pharma’s cannabis drug OK’d by European Medicines Agency panel

July 26, 2019 · Updated November 5, 2019

GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests […]

Read More

South Korean medical cannabinoid imports surpass 300 units since law passed

July 25, 2019 · Updated July 26, 2019

South Korea saw just over 300 approved imports of cannabinoid-based medicines in the first few months of the country’s newly regulated medical cannabis program, a volume that underwhelmed local experts who expected demand to be much higher. Almost all the medical cannabis prescriptions were for pure CBD oil. Through July 19, exactly 300 prescriptions had been […]

Read More

Canadian marijuana firm Sundial, California’s KushCo seek Nasdaq listings

July 8, 2019 · Updated July 10, 2019

Sundial Growers, a Canadian cannabis company, and California-based KushCo Holdings have applied to be listed on the Nasdaq. Sundial, based in Calgary, Alberta, would operate under the ticker symbol SNDL. The number of shares to be offered and the price range for the offering have not been determined. The company currently operates two facilities in its […]

Read More

Week in Review: MJBizConNEXT in New Orleans, OR preps for future interstate MJ potentials, NV cannabis board & more

June 14, 2019 · Updated June 17, 2019

The cannabis industry descends on New Orleans to explore emerging trends at MJBizConNEXT, Oregon lawmakers pass a bill that would empower it to make agreements with other states for the transfer of marijuana, Nevada creates a cannabis control board and says no to social use licensing for now – plus other important news from around the industry. […]

Read More

Billionaire-backed Chinese firm plans Asia’s first e-commerce CBD platform

June 13, 2019 · Updated June 25, 2019

A company backed by United Kingdom billionaire Jim Mellon and Nuuvera co-founder Lorne Abony plans to establish what they say will be Asia’s first e-commerce platform focusing on CBD-infused products. The pair are part of a group of investors in Hong Kong-headquartered Regent Pacific that is closing in on a $15 million all-stock takeover of […]

Read More

European nonprofits take lead in CBD safety testing, call for consistent standards

May 29, 2019

The popularity of CBD in Europe is on the rise, even though the market has no clear rules nor industrywide standards to ensure reliable and safe products across the continent. For consumers, this means that legitimate products can often be found right next to others with significantly less CBD than advertised or with potentially harmful contaminants. […]

Read More

Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement

May 6, 2019

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago. The maker of cannabis-derived medications, including Sativex and Epidiolex, recorded a net loss for the quarter of $50.1 million compared with a year-ago net loss of $69.5 million. […]

Read More